The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.
Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men
Abstract
Transdermal testosterone (T) delivery represents an effective alternative to injectable androgens. We studied 163 hypogonadal men who applied 5, 7.5, or 10 g AndroGel (T gel) 1% CIII per day for up to 42 months. Efficacy data were presented in 123 subjects considered evaluable. Continuous AndroGel treatment normalized mean serum T and free T levels. Mean serum 5alpha-dihydrotestosterone concentrations and 5alpha-dihydrotestosterone/T ratio slightly increased, mean serum estradiol/T ratio doubled, and mean serum FSH and LH levels were suppressed by T replacement. Sexual function and mood parameters improved rapidly and were maintained throughout T treatment. Lean body mass increased (P = 0.0001) and fat mass decreased (P = 0.0001), and these changes were maintained with treatment but were not accompanied by significant increases in muscle strength. Increases in serum bone markers suggestive of increased bone formation were followed by gradual and progressive increases in bone mineral density more in the spine (P = 0.0001) than the hip (P = 0.0004). Mild local skin irritation occurred in 12 subjects, resulting in discontinuation in only one subject. Except for the anticipated increase in hematocrit and hemoglobin, there were no clinically significant changes in blood counts or biochemistry. In three subjects with elevated serum prostate-specific antigen, prostate biopsies showed cancer. We conclude that continued application of AndroGel resulted in beneficial effects similar to those with injectables and other transdermal preparations. This study was neither placebo controlled nor powered to determine the effects of T treatment on prostate cancer risk. Thus, monitoring for prostatic disease and assessment for erythrocytosis are strongly advised to reduce the risk of adverse events with T treatment of hypogonadal men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Treatment increases BMD (132-135) and improves trabecular structure (136) and bone mechanical properties (137).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [137]
In the citing paper
“Prostate-specific antigen and volume rise, marginally, plateauing at 12 months; further increase should be related to aging rather than therapy.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [87]
In the citing paper
“In a study of 123 subjects over 42 months of testosterone gel application, there was significant increase in serum PSA over the first 6 months and then no further significant increases with continued testosterone treatment was found (87).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,588
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
The Influence of Finasteride on the Development of Prostate Cancer
Sathianathen, N. J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,082
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Self-citationKatznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791
Effects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Self-citationTestosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, J., Lee, W. P., Bunnell, T. J., & Casaburi, R. H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3733 · Cited by 596
Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4163 · Cited by 559
Flagged first, then by citations
3 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 655
Semirale, A. A., Zhang, X., & Wiren, K. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23098 · Cited by 42
“Androgen treatment [Wang et al., 2004] and anabolic steroid use/abuse [Hartgens and Kuipers, 2004] can alter and/or ameliorate these changes.”
BackgroundKelly, O. J., Gilman, J. C., & Ilich, J. Z. (2018) · Nutrients · doi:10.3390/nu10010107 · Cited by 48
Kathrins, M. N., Doersch, K., Nimeh, T., Canto, A., Niederberger, C., & Seftel, A. D. (2015) · Urology · doi:10.1016/j.urology.2015.11.006 · Cited by 41
Associations of androgens with depressive symptoms and cognitive status in the general population
Kische, H., Groß, S., Wallaschofski, H., Grabe, H. J., Völzke, H., Nauck, M. A., & Haring, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177272 · Cited by 41
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 48
Self-citationTestosterone depot injection in male hypogonadism: a critical appraisal.
Yassin, A. A., & Haffejee, M. (2007) · PubMed Central · Cited by 41
Morales, Á., Bella, A. J., Chun, S., Jc, L., Assimakopoulos, P., Bebb, R. A., Gottesman, I. S., Alarie, P., Dugré, H., & Elliott, S. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.880 · Cited by 40
Seidman, S. N., & Roose, S. P. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600575355 · Cited by 40
Adherence to treatment in men with hypogonadotrophic hypogonadism
Dwyer, A. A., Tiemensma, J., Quinton, R., Pitteloud, N., & Morin, D. (2016) · Clinical Endocrinology · doi:10.1111/cen.13236 · Cited by 41
Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum
Dichtel, L. E., Lawson, E. A., Haines, M. S., Meenaghan, E. M., Paskal, M. L., Eddy, K. T., Pinna, G., Nelson, M., Rasmusson, A. M., Klibanski, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.269 · Cited by 40
Neuropsychiatric Aspects in Men with Klinefelter Syndrome
Giagulli, V. A., Campone, B., Castellana, M., Salzano, C., Fisher, A. D., de Angelis, C., Pivonello, R., Colao, A., Pasquali, D., Maggi, M., et al. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666180703160250 · Cited by 40
Alberti, I., Grenier, A., Kraus, H., & Carrara, D. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.935 · Cited by 40
Do androgens play any role in the physical frailty of ageing men?
O’Connell, M. D. L., Tajar, A., Roberts, S. A., & Wu, F. C. W. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01093.x · Cited by 39
Role of hormones in bone remodeling in the craniofacial complex: A review
Tunheim, E. G., Skallevold, H. E., & Rokaya, D. (2023) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2023.01.009 · Cited by 38
Miner, M. M., & Seftel, A. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01317.x · Cited by 37
ANABOLIC AGENTS FOR IMPROVING MUSCLE REGENERATION AND FUNCTION AFTER INJURY
Lynch, G. S., Schertzer, J. D., & Ryall, J. G. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04955.x · Cited by 38
Kim, C., Ahn, J., Moon, J.-W., Kim, S., Chae, H., & Kang, B. (2014) · Development & Reproduction · doi:10.12717/dr.2014.18.3.145 · Cited by 38
Lašaitė, L., Čeponis, J., Preikša, R. T., & Žilaitienė, B. (2016) · Andrologia · doi:10.1111/and.12633 · Cited by 37
Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates
Mohler, M. L., Nair, V. A., Hwang, D., Rakov, I. M., Patil, R., & Miller, D. D. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.11.1565 · Cited by 37
Male hormonal contraception: looking back and moving forward
Roth, M. Y., Page, S. T., & Bremner, W. J. (2015) · Andrology · doi:10.1111/andr.12110 · Cited by 36
Janjgava, S., Zerekidze, T., Uchava, L., Giorgadze, E., & Asatiani, K. (2014) · European journal of medical research · doi:10.1186/s40001-014-0056-6 · Cited by 38
The Long and Tortuous History of the Discovery of Testosterone and Its Clinical Application
Morales, Á. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12081 · Cited by 35
Minnemann, T., Schubert, M., Freude, S., Hübler, D., Gouni-Berthold, I., Schumann, C. Y., Christoph, A., Oettel, M., Ernst, M. E., Mellinger, U., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346421 · Cited by 35
How hormones mediate trade-offs in human health and disease
Bribiescas, R. G., & Ellison, P. T. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0007 · Cited by 36
Kaminetsky, J. C., Moclair, B., Hemani, M. L., & Sand, M. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02196.x · Cited by 35
Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization
ORWOLL, E. S., & KLEIN, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50044-6 · Cited by 35
Nightingale, T. E., Moore, P. D., Harman, J., Khalil, R. E., Gill, R. S., Castillo, T. A., Adler, R. A., & Gorgey, A. S. (2017) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2017.1357917 · Cited by 37
Wang, X., Smith, G. I., Patterson, B. W., Reeds, D. N., Kampelman, J., Magkos, F., & Mittendorfer, B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00533.2011 · Cited by 34
Yassin, A. A., Salman, M., Alzubaidi, R. T., & Yassin, D. (2017) · The Aging Male · doi:10.1080/13685538.2017.1298584 · Cited by 33
Emmelot‐Vonk, M. H., Verhaar, H. J. J., Nakhai-Pour, H. R., Grobbee, D. E., & van der Schouw, Y. T. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.5 · Cited by 32
Biochemical endocrinology of the hypogonadal male
Belchetz, P. E., Barth, J. H., & Kaufman, J. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010150 · Cited by 32
Metabolic syndrome and hypogonadism – two peas in a pod
Ebrahimi, F., & Christ‐Crain, M. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14283 · Cited by 32
Advances in Testosterone Replacement Therapy
Gooren, L. J. (2008) · Frontiers of hormone research · doi:10.1159/000175842 · Cited by 31
Testosterone, Thrombophilia, and Thrombosis
Glueck, C. J., Richardson-Royer, C., Schultz, R., Burger, T., Labitue, F., Riaz, M. K., Padda, J., Bowe, D., Goldenberg, N., & Wang, P. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613485154 · Cited by 32
Collier, C. P., CLARK, A. F., Bain, J., Godwin, M. S., Collier, C. P., CLARK, A. F., Bain, J., Godwin, M. S., Hudson, R. W., Lepage, R., et al. (2007) · The Aging Male · doi:10.1080/13685530701600802 · Cited by 30
Moringa Oleifera Leaves Extract Attenuates Male Sexual Dysfunction
Sharmila (2012) · Neuroscience International · doi:10.3844/amjnsp.2012.17.24 · Cited by 31
Beyond the Condom: Frontiers in Male Contraception
Roth, M. Y., & Amory, J. K. (2016) · Seminars in Reproductive Medicine · doi:10.1055/s-0036-1571435 · Cited by 31
Grober, E. D., Khera, M., Soni, S. D., Espinoza, M. G., & Lipshultz, L. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901618 · Cited by 30
Gould, D. C., & Kirby, R. S. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500839 · Cited by 29
Seidman, S. N., & Klein, D. F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1167 · Cited by 30
Testosterone and Prostate Cancer: What are the Risks for Middle-Aged Men?
Morgentaler, A. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.02.002 · Cited by 29
Assessment of Sex Differences in Body Composition Among Adolescents With Anorexia Nervosa
Nagata, J. M., Golden, N. H., Peebles, R., Long, J., Murray, S. B., Leonard, M. B., & Carlson, J. L. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.11.005 · Cited by 29
Khodamoradi, K., Khosravizadeh, Z., Parmar, M., Kuchakulla, M., Ramasamy, R., & Arora, H. (2020) · F&S Reviews · doi:10.1016/j.xfnr.2020.11.001 · Cited by 29
Barrett, E. S., Parlett, L. E., Wang, C., Drobnis, E. Z., Redmon, J. B., & Swan, S. H. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.10.003 · Cited by 30
Self-citationAndrogen Deficiency in Aging and Metabolically Challenged Men
Shelton, J. B., & Rajfer, J. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.007 · Cited by 30
Androgens and male aging: current evidence of safety and efficacy
Gooren, L. J. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.4 · Cited by 29
Normative hypogonadism and depression: does ‘andropause’ exist?
Seidman, S. N. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901443 · Cited by 29
Hormones, Metabolism, Aging and Men's Health
Buvat, J., Shabsigh, R., Guay, A. T., Gooren, L. J., Torres, L. O., MEULEMAN, E. J. H., & Graziottin, A. (2006) · Wiley eBooks · doi:10.1002/9780470755235.ch18 · Cited by 29
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish, A. M. (2016) · Korean journal of urology · doi:10.4111/icu.2016.57.6.384 · Cited by 28
Short-Acting Testosterone: More Physiologic?
Westfield, G., Kaiser, U. B., Lamb, D. J., & Ramasamy, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572465 · Cited by 28
Pellikaan, K., Brahim, Y. B., Rosenberg, A. G. W., Davidse, K., Poitou, C., Coupaye, M., Goldstone, A. P., Höybye, C., Markovic, T., Grugni, G., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194361 · Cited by 29
Differing levels of testosterone and the prostate: a physiological interplay
Goldenberg, S. L., Koupparis, A. J., & Robinson, M. E. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.79 · Cited by 27
Kimball, A., Haines, M. S., Meenaghan, E. M., Bachmann, K. N., Eddy, K. T., Misra, M., Lawson, E. A., Kreiger-Benson, E., Herzog, D. B., Koman, S. L., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00828 · Cited by 30
Walsh, J., Marshall, H. C., Smith, I. L., Greenfield, D., Swain, J., Best, E. L., Ashton, J., Brown, J. M., Huddart, R. A., Coleman, R. E., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002960 · Cited by 29
Clinical use of testosterone in hypogonadism and other conditions
Nieschlag, E., & Behre, H. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.015 · Cited by 28
Kumsar, Ş., Kumsar, N. A., Sağlam, H. S., Köse, O., Budak, S., & Adsan, Ö. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12394 · Cited by 30
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00043.x · Cited by 27
Smith, R. P., Khanna, A., Coward, R. M., Rajanahally, S., Kovac, J. R., Gonzales, M., & Lipshultz, L. I. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12226 · Cited by 28
Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome
Tolrà, J. R., Barreda, J. T., del Río, L., Gregorio, S. D., & Miranda, E. F. (2013) · The Aging Male · doi:10.3109/13685538.2013.839648 · Cited by 27
Hamilton, L. D., Dam, D. V., & Wassersug, R. J. (2015) · Psycho-Oncology · doi:10.1002/pon.3930 · Cited by 27
Testosterone deficiency and cardiovascular mortality
Morgentaler, A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143248 · Cited by 28
Osteopenia and male hypogonadism.
Dupree, K., & Dobs, A. S. (2004) · Europe PMC (PubMed Central) · Cited by 27
Self-citationThirumalai, A., Cooper, L. A., Rubinow, K. B., Amory, J. K., Lin, D. W., Wright, J. L., Marck, B. T., Matsumoto, A. M., & Page, S. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1483 · Cited by 27
Self-citationTestosterone replacement therapy and the risk of prostate cancer. Is there a link?
Barqawi, A. B., & Crawford, E. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901418 · Cited by 27
Birzniece, V., Meinhardt, U. J., Handelsman, D. J., & Ho, K. K. Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03524.x · Cited by 27
Hepatic actions of androgens in the regulation of metabolism
Birzniece, V. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000405 · Cited by 28
Evolution, developmental plasticity, and metabolic disease
Kuzawa, C. W., Gluckman, P. D., Hanson, M. A., & Beedle, A. S. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0019 · Cited by 27
Testosterone deficiency and the metabolic syndrome
Lunenfeld, B. (2007) · The Aging Male · doi:10.1080/13685530701390800 · Cited by 27
Signaling pathways implicated in androgen regulation of endocortical bone
Wiren, K. M., Semirale, A. A., Hashimoto, J. G., & Zhang, X. W. (2009) · Bone · doi:10.1016/j.bone.2009.10.039 · Cited by 25
Malik, R. D., Wang, C. E., Lapin, B., Lakeman, J. C., & Helfand, B. T. (2015) · Urology · doi:10.1016/j.urology.2015.01.027 · Cited by 26
Self-citationLifestyle, diet, and disease: comparative perspectives on the determinants of chronic health risks
Leonard, W. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0020 · Cited by 26
Fui, M. N. T., Hoermann, R., Nolan, B. J., Clarke, M., Zajac, J. D., & Grossmann, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-27481-3 · Cited by 26
Testosterone Replacement Therapy in Men with Prostate Cancer: A Time-Varying Analysis
Kaplan, A. L., Lenis, A. T., Shah, A., Rajfer, J., & Hu, J. C. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12768 · Cited by 26
Androgen Replacement in Men Undergoing Treatment for Prostate Cancer
Rhoden, E. L., Averbeck, M. A., & Telöken, P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00925.x · Cited by 26
Delivery options for contraceptives
Sitruk-Ware, R. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03499-9 · Cited by 26
Papadopoulos, E., Irving, B. A., Brown, J. C., Heymsfield, S. B., Sattar, S., Alibhai, S. M. H., Williams, G. R., & Dunne, R. F. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01252-y · Cited by 28
Testosterone, thrombophilia, thrombosis
Glueck, C. J., Friedman, J., Hafeez, A., Hassan, A., & Wang, P. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000126 · Cited by 25
Leung, D. G., Germain‐Lee, E. L., Denger, B., & Wagner, K. R. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.04.008 · Cited by 25
Obstructive Sleep Apnea and Testosterone Therapy
Payne, K. S., Lipshultz, L. I., Hotaling, J. M., & Pastuszak, A. W. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.04.004 · Cited by 25
Advances in male hormone substitution therapy
Qoubaitary, A., Swerdloff, R. S., & Wang, C. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1493 · Cited by 25
Self-citationGonzales, R. J. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1267-3 · Cited by 27
Misra, M., Katzman, D. K., Cord, J., Manning, S. J., Mickley, D. W., Herzog, D. B., Miller, K. K., & Klibanski, A. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26273 · Cited by 25
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00137-4 · Cited by 26
The Effects of Treating Male Hypogonadism on Couples’ Sexual Desire and Function
Conaglen, J. V., & Conaglen, H. M. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01043.x · Cited by 25
Kaufman, J. M., Miller, M. G., Fitzpatrick, S. B., McWhirter, C. L., & Brennan, J. J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02630.x · Cited by 25
Szulc, P. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101624 · Cited by 26
Quality of life is reduced in patients with Klinefelter syndrome on androgen replacement therapy
de Ronde, W., de Haan, A., & Drent, M. L. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0689 · Cited by 24
Androgen Deficiency in the Aging Male
Morales, Á., & Heaton, J. P. W. (2005) · Humana Press eBooks · doi:10.1385/1-59259-871-4:279 · Cited by 23
Stahlman, J., Britto, M. R., Fitzpatrick, S. B., McWhirter, C. L., Testino, S. A., Brennan, J. J., & ZumBrunnen, T. L. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.652732 · Cited by 23
Testosterone therapy and cancer risk
Eisenberg, M. L., Li, S., Betts, P., Herder, D., Lamb, D. J., & Lipshultz, L. I. (2014) · British Journal of Urology · doi:10.1111/bju.12756 · Cited by 23
Olabiyi, A. A., Oboh, G., & Adefegha, S. A. (2016) · Journal of Food Biochemistry · doi:10.1111/jfbc.12351 · Cited by 23
Elsherbiny, A., Tricomi, M., Bhatt, D., & Dandapantula, H. K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0838-x · Cited by 23
Germ cell loss in Klinefelter syndrome: When and why?
Willems, M., Gies, I., & Saen, D. V. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31787 · Cited by 23
The latest options and future agents for treating male hypogonadism
Edelstein, D. L., Sivanandy, M. S., Shahani, S., & Basaria, S. S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.2991 · Cited by 23
Klotho: An Emerging Factor With Ergogenic Potential
Arroyo, E., Troutman, A. D., Moorthi, R. N., Avin, K. G., Coggan, A. R., & Lim, K. J. (2022) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.807123 · Cited by 26
Wiren, K. M., Hashimoto, J. G., Semirale, A. A., & Zhang, X.-W. (2011) · Bone · doi:10.1016/j.bone.2011.06.010 · Cited by 21
Rais, M., Wilson, R. M., Urbanski, H. F., & Messaoudi, I. (2017) · GeroScience · doi:10.1007/s11357-017-9979-5 · Cited by 22
Testosterone replacement therapy and the risk of stroke in men: A systematic review
Loo, S. Y., Chen, B. Y., Yu, O. H. Y., Azoulay, L., & Renoux, C. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.08.013 · Cited by 22
Bone involvement in males with Kallmann disease
Iolascon, G., Frizzi, L., Bianco, M., Gimigliano, F., Palumbo, V., Sinisi, A. M., & Sinisi, A. A. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0421-5 · Cited by 22
Testosterone treatment to mimic hormone physiology in androgen replacement therapy
Fabbri, A., Isidori, A. M., Giannetta, E., & Lenzi, A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1093 · Cited by 22
Metadata
- Authors
- Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S.
- Affiliations
- University of California, Los Angeles (US)
- Baylor College of Medicine (US)
- Johns Hopkins University (US)
- Veterans Health Administration (US)
- University of Washington (US)
- University of Pennsylvania Health System (US)
- Duke Medical Center (US)
- Corresponding author
- Wang, Christina
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-05
- Volume
- 89
- Issue
- 5
- Pages
- 2085-2098
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001118572
- Semantic Scholar
- 2114ced4c5aa202f6d1a0eee503c76ffef92a68a
- Cited by
- 656
- References
- 48
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 4 · 2023: 14 · 2022: 24 · 2021: 6 · 2020: 15 · 2019: 23 · 2018: 23 · 2017: 36 · 2016: 22 · 2015: 30 · 2014: 36 · 2013: 37 · 2012: 40
- FWCI
- 32.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- University of Pennsylvania
- Johns Hopkins University
- Deutsches Krebsforschungszentrum
- National Institutes of Health (RR00425)
- National Center for Research Resources (M01RR000030, M01RR000425)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone replacement therapy, transdermal testosterone, hypogonadism, sexual function, mood, lean body mass, fat mass, bone mineral density, dihydrotestosterone, estradiol, gonadotropin suppression, erythrocytosis, prostate-specific antigen, prostate cancer risk, long-term treatment
- MeSH terms
- Adolescent, Adult, Affect, Aged, Androgens, Body Composition, Dose-Response Relationship, Drug, Drug Administration Schedule, Estradiol, Follicle Stimulating Hormone, Gels, Hematocrit, Hemoglobins, Humans, Hypogonadism, Luteinizing Hormone, Male, Prostatic Hyperplasia, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Ultrasonography, Biomarkers, Bone Density, Bone Remodeling, Prostate-Specific Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review